Firefly Neuroscience, Inc.
AIFF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $108 | $498 | $0 | $32 |
| % Growth | -78.3% | – | -100% | – |
| Cost of Goods Sold | $67 | $0 | $0 | $0 |
| Gross Profit | $41 | $498 | $0 | $32 |
| % Margin | 38% | 100% | – | 100% |
| R&D Expenses | $1,954 | $741 | $1,272 | $2,926 |
| G&A Expenses | $6,133 | $2,196 | $1,915 | $1,661 |
| SG&A Expenses | $7,334 | $2,835 | $1,980 | $1,681 |
| Sales & Mktg Exp. | $1,201 | $639 | $65 | $20 |
| Other Operating Expenses | -$67 | $0 | $77 | $79 |
| Operating Expenses | $9,221 | $3,576 | $3,329 | $4,686 |
| Operating Income | -$9,180 | -$3,078 | -$3,329 | -$4,654 |
| % Margin | -8,500% | -618.1% | – | -14,543.8% |
| Other Income/Exp. Net | -$1,278 | $476 | -$460 | $273 |
| Pre-Tax Income | -$10,458 | -$2,602 | -$3,789 | -$4,381 |
| Tax Expense | $2 | $1 | $0 | $0 |
| Net Income | -$10,460 | -$2,603 | -$3,789 | -$4,381 |
| % Margin | -9,685.2% | -522.7% | – | -13,690.6% |
| EPS | -1.6 | -0.33 | -0.48 | -0.56 |
| % Growth | -384.8% | 31.2% | 14.3% | – |
| EPS Diluted | -1.6 | -0.33 | -0.48 | -0.56 |
| Weighted Avg Shares Out | 6,547 | 7,870 | 7,870 | 7,870 |
| Weighted Avg Shares Out Dil | 6,547 | 7,870 | 7,870 | 7,870 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $69 | $18 | $574 | $135 |
| Depreciation & Amortization | $67 | $0 | $14 | $429 |
| EBITDA | -$10,322 | -$2,584 | -$3,201 | -$3,817 |
| % Margin | -9,557.4% | -518.9% | – | -11,928.1% |